Targeted viral testing
Rapid, accurate confirmation
Symptom validation insight
West Nile Virus (WNV) is often missed or misdiagnosed because early symptoms can resemble a generic viral illness. In some patients, it can progress to neurologic involvement.
This panel is ideal for individuals experiencing fever, headache, or body aches without a clear cause, severe fatigue after a viral-like illness, neck stiffness, weakness, or neurologic symptoms. It is also appropriate for those recently exposed to mosquitoes, whose symptoms worsened rather than improved, or who want clarity after travel or outdoor exposure instead of assuming a generic viral illness.
This panel includes West Nile–specific blood testing, phlebotomy coordination, clinical interpretation by a medical provider, guidance for symptom monitoring and care, and escalation recommendations if needed.
Yes. IgM testing identifies recent or active West Nile Virus exposure shortly after infection.
Yes. Total antibody testing helps confirm whether the infection is ongoing or occurred in the past.
Your provider will guide monitoring based on results, especially if neurologic symptoms are present.
No. West Nile Virus requires targeted testing and is not included in standard viral panels.
